标题
Alternative therapies against Mycobacterium abscessus infections
作者
关键词
-
出版物
CLINICAL MICROBIOLOGY AND INFECTION
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-11-04
DOI
10.1016/j.cmi.2023.10.001
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin
- (2023) Ivana Palucci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Biotin-dependent cell envelope remodelling is required for Mycobacterium abscessus survival in lung infection
- (2023) Mark R. Sullivan et al. Nature Microbiology
- Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria
- (2023) Matteo Mori et al. Pharmaceutics
- Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease
- (2023) Sarah A.R. Siegel et al. CHEST
- Eradication of Mycobacterium abscessus infection in cystic fibrosis with initiation of Elexacaftor/Tezacaftor/Ivacaftor
- (2023) Caoimhe McParland et al. Journal of Cystic Fibrosis
- Efficacy of PBTZ169 and pretomanid against Mycobacterium avium, Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum in BALB/c mice models
- (2023) Luyao Zheng et al. Frontiers in Cellular and Infection Microbiology
- Mycobacterial biotin biosynthesis counters airway alkalinity
- (2023) Wassim Daher et al. Nature Microbiology
- Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus
- (2022) Juan Manuel Belardinelli et al. Science Translational Medicine
- Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection
- (2022) Noemi Poerio et al. Microbiology Spectrum
- Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection
- (2022) Jerry A. Nick et al. CELL
- A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity In Vitro and In Vivo
- (2022) Wenye Wu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phage Therapy of Mycobacterium Infections: Compassionate-use of Phages in Twenty Patients with Drug-Resistant Mycobacterial Disease
- (2022) Rebekah M. Dedrick et al. CLINICAL INFECTIOUS DISEASES
- Investigating the Antituberculosis Activity of Selected Commercial Essential Oils and Identification of Active Constituents Using a Biochemometrics Approach and In Silico Modeling
- (2022) Katyna J. Boussamba-Digombou et al. Antibiotics-Basel
- Mycobacterium abscessus Mutants with a Compromised Functional Link between the Type VII ESX-3 System and an Iron Uptake Mechanism Reliant on an Unusual Mycobactin Siderophore
- (2022) Glennon V. Bythrow et al. Pathogens
- In Vitro and In Vivo Activity of Gepotidacin against Drug-Resistant Mycobacterial Infections
- (2022) Mohammad Naiyaz Ahmad et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preclinical murine models to study lung infection with Mycobacterium abscessus complex
- (2022) Francesca Nicola et al. TUBERCULOSIS
- Host‐directed therapy to combat mycobacterial infections*
- (2021) Gül Kilinç et al. IMMUNOLOGICAL REVIEWS
- Beyond phenotype: The genomic heterogeneity of co-infecting Mycobacterium abscessus smooth and rough colony variants in cystic fibrosis patients
- (2021) Ana Victoria Gutiérrez et al. Journal of Cystic Fibrosis
- Pipeline of anti‐ Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities
- (2021) Anna Egorova et al. MEDICINAL RESEARCH REVIEWS
- Stepwise pathogenic evolution of Mycobacterium abscessus
- (2021) Josephine M. Bryant et al. SCIENCE
- Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance
- (2021) Rebekah M. Dedrick et al. mBio
- Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis
- (2021) Stefanie Krug et al. Frontiers in Immunology
- Phage Therapy for Antibiotic-Resistant Bacterial Infections
- (2021) Graham F. Hatfull et al. Annual Review of Medicine
- Mycobacteriophage–antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus
- (2021) Matt D. Johansen et al. Disease Models & Mechanisms
- The Antimalarial Mefloquine Shows Activity against Mycobacterium abscessus, Inhibiting Mycolic Acid Metabolism
- (2021) Giulia Degiacomi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against Mycobacterium abscessus
- (2021) Da-Gyum Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mycobacteria–host interactions in human bronchiolar airway organoids
- (2021) Nino Iakobachvili et al. MOLECULAR MICROBIOLOGY
- Antibacterial peptide RP557 increases the antibiotic sensitivity of Mycobacterium abscessus by inhibiting biofilm formation
- (2021) Bing Li et al. SCIENCE OF THE TOTAL ENVIRONMENT
- Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model
- (2021) Arundhati Maitra et al. Antibiotics-Basel
- Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
- (2020) Matt D. Johansen et al. NATURE REVIEWS MICROBIOLOGY
- Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus
- (2020) Rose C. Lopeman et al. Scientific Reports
- Untargetted Metabolomic Exploration of the Mycobacterium tuberculosis Stress Response to Cinnamon Essential Oil
- (2020) Elwira Sieniawska et al. Biomolecules
- Rifabutin is bactericidal against intracellular and extracellular forms of Mycobacterium abscessus
- (2020) Matt D. Johansen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Alternative and Experimental Therapies of Mycobacterium abscessus Infections
- (2020) Michal Meir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria
- (2019) Swetarka Das et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections
- (2019) Brandon Banaschewski et al. Journal of Cystic Fibrosis
- Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
- (2019) Rebekah M. Dedrick et al. NATURE MEDICINE
- Rifabutin is active against Mycobacterium abscessus in mice
- (2019) Thomas Dick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pretomanid: First Approval
- (2019) Susan J. Keam DRUGS
- Ginger essential oil and fractions against Mycobacterium spp.
- (2019) Vanessa Pietrowski Baldin et al. JOURNAL OF ETHNOPHARMACOLOGY
- Host Directed Therapies for Tuberculosis: Futures Strategies for an Ancient Disease
- (2018) Ivana Palucci et al. CHEMOTHERAPY
- Inhaled granulocyte–macrophage colony-stimulating factor forMycobacterium abscessusin cystic fibrosis
- (2018) John P. Scott et al. EUROPEAN RESPIRATORY JOURNAL
- Identification of genes required forMycobacterium abscessusgrowth in vivo with a prominent role of the ESX-4 locus
- (2018) Laura Laencina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjunctive use of celecoxib with anti-tuberculosis drugs: evaluation in a whole-blood bactericidal activity model
- (2018) Claire M. Naftalin et al. Scientific Reports
- “In vitro” activity of Melaleuca cajuputi against mycobacterial species
- (2018) Alessandra Bua et al. NATURAL PRODUCT RESEARCH
- MmpL8MAB controls Mycobacterium abscessus virulence and production of a previously unknown glycolipid family
- (2018) Violaine Dubois et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibiofilm activity of nanoemulsions of Cymbopogon flexuosus against rapidly growing mycobacteria
- (2017) Grazielle Guidolin Rossi et al. MICROBIAL PATHOGENESIS
- Compassionate Nitric Oxide Adjuvant Treatment of Persistent Mycobacterium Infection in Cystic Fibrosis Patients
- (2017) Karin Yaacoby-Bianu et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
- (2016) Robert S Wallis et al. LANCET INFECTIOUS DISEASES
- Deletion of a dehydratase important for intracellular growth and cording renders roughMycobacterium abscessusavirulent
- (2016) Iman Halloum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Novel Therapeutic Approach Using Mesenchymal Stem Cells to Protect Against Mycobacterium abscessus
- (2016) Jong-Seok Kim et al. STEM CELLS
- Modeling the Mycobacterium tuberculosis Granuloma – the Critical Battlefield in Host Immunity and Disease
- (2013) Evelyn Guirado et al. Frontiers in Immunology
- In vitroeffects of citrus oils againstMycobacterium tuberculosisand non-tuberculousMycobacteriaof clinical importance
- (2012) Philip G. Crandall et al. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART B-PESTICIDES FOOD CONTAMINANTS AND AGRICULTURAL WASTES
- Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae
- (2011) S. Chopra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhibition of Bacterial Multidrug Resistance by Celecoxib, a Cyclooxygenase-2 Inhibitor
- (2010) Arunasree M. Kalle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search